Webinar Preview
Despite the introduction of many novel ophthalmology treatments in recent years, there is still a need for more cost-effective and patient-friendly treatments that reduce patient burden and provide improved outcomes.
With an aging population and increasing incidence of chronic diseases, the number of patients suffering from eye disorders continues to rise. Drug developers have responded, leading to a full pipeline with many early phase candidates advancing to later-stage clinical trials.
Join this webinar to learn about the current landscape, challenges of late-phase ophthalmology trials and key insights to ensure on-time trial delivery and success.
Speakers
Jennifer Christiansen, PhD, Senior Director, Deputy Pillar Head, Ophthalmology, PPD Clinical Research Business of Thermo Fisher Scientific
Dr. Jennifer Christiansen is a customer-focused Senior Director within project management, with 20+ years of experience in the ophthalmic clinical research and pharmaceutical industry space. She has spent more than 13 years in the contract research organization (CRO) industry, all at the PPD clinical research business of Thermo Fisher Scientific.
Prior to that time, she worked on the sponsor side at Alcon. She currently serves as the Deputy Pillar Head in Ophthalmology. In this role, she collaborates on strategy for the yearly goals in the company’s ophthalmic book of business and serves as executive oversight for studies in anterior ophthalmic indications.
Read more...
Dr. Christiansen holds a PhD and MS in Experimental Psychology from Texas Christian University, with a prior faculty position in academia. She received the Young Alumni Achievement Award in 2003 from Texas Wesleyan University. She is a subject matter expert for glaucoma and has led multiple glaucoma programs, including the first implant studies to receive registration approval in that indication.
Read Less...
Tracey Roberts, MS, Executive Director, Pillar Head, Ophthalmology, PPD Clinical Research Business of Thermo Fisher Scientific
Ms. Tracey Roberts has served in both biopharma and contract research organization (CRO) companies for more than 25 years, with more than 19 years at the PPD clinical research business of Thermo Fisher Scientific, where she is currently an Executive Director and Pillar Head, Ophthalmology, thus providing strategic leadership and guidance within project management. She contributes operational subject matter expertise, provides senior level oversight and is responsible for escalations for the company’s ophthalmology book of business.
Read more...
As a subject matter expert for retinal diseases, including products that were approved in diabetic macular edema and age-related macular degeneration, she provides senior leadership escalation with a focus on strategic risk management and contingency plans to meet study deliverables. Ms. Roberts holds a BS in Biology with an MS in Clinical Development from George Washington University.
Read Less...
Dr. Debra Schaumberg, ScD, OD, MPH, Vice President & Global Head, Strategic Development Consulting; Chair, Research Leadership Council, PPD Clinical Research Business of Thermo Fisher Scientific
An internationally recognized expert in ophthalmology clinical research, Dr. Schaumberg brings to the life sciences community more than 25 years of expertise and experience leading clinical development and medical affairs strategy.
She has developed and led numerous research and development programs spanning the spectrum of early to late clinical development through medical affairs, including all aspects of evidence generation and integration for drugs, biologics, devices and diagnostics.
Read more...
Previously, Dr. Schaumberg served on the faculties of Harvard Medical School and the Harvard TH Chan School of Public Health, as well as the University of Utah School of Medicine. She formerly served as the Global Medical Director for Ophthalmics and as the Head of Medical Evidence at Shire. She has authored hundreds of scientific publications, lectures and scientific presentations.
Dr. Schaumberg received her ScD from the Harvard TH Chan School of Public Health, an MPH from the Johns Hopkins Bloomberg School of Hygiene and Public Health, a research fellowship at the Johns Hopkins School of Medicine and OD summa cum laude from the Illinois College of Optometry.
Read Less...
Lisa Williams, LPN, Senior Director, Clinical Trial Services, CorEvitas Vestrum Health Data
Williams serves as Senior Director of Clinical Trial Services and is responsible for overseeing business development and operations. She has been with the company since 2021 and has served in several roles helping to build out and develop the patient identification offering. She graduated with her AAS from an accredited ophthalmic technician program in 2008 and obtained her LPN license in 2012.
Her background is in ophthalmology, most specifically retina, as a scribe, photographer and study coordinator. She also worked as a bedside nurse for several years while serving as the operations manager for her family business.
Read more...
Read Less...
Who Should Attend?
This webinar will appeal to:
- CEOs
- Chief Medical Officers
- Scientific Officers
- Clinical monitors
- Clinical development/operations/research
- Clinical Scientists/Research Managers
- Medical Affairs Specialists
- Medical monitors
- Protocol Managers
- Senior Managers, Trial Initiation
- TA experts in Ophthalmology
What You Will Learn
Attendees will learn about:
- The changing landscape and challenges of late-stage ophthalmic trials
- The importance of country and site selection in proactive planning
- Ways to empower sites and reduce site burden
- Critical strategies for timely trial delivery and overall success
Xtalks Partner
PPD clinical research business of Thermo Fisher Scientific Inc.
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, enables customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, their capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services. Recognized as a global industry leader in accelerating promising medicines from early development through regulatory approval and market access, they serve pharma, biotech, medical device and government organizations with custom-tailored solutions, including full-service partnerships and functional service partnerships. As a strategic partner in clinical development and analytical services, they apply cutting edge technologies, therapeutic expertise and a firm commitment to quality to help customers deliver life-changing therapies.
Related Webinars
Fast, Faster, Fastest: Is It Time for Automated Model Building?
Maximizing Patient Recruitment in Rare Neurological Clinical Studies
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account